Progress in Mind
Your first-stop resource for the latest news from ISPOR 2018
Choose a channel
Check out the different Progress in Mind content channels.
Mental health
Congress highlights
Transforming healthcare — the changing landscape of patient engagement
Patient engagement is the facilitation and strengthening of the role of patients as co-producers of...
Mental health
Congress highlights
Early dialogues with patients are informing medicines development
A 200-strong audience of health economics and outcomes research professionals at ISPOR 2018...
Article
Points from posters at the Parkinson’s Disease Therapeutic Conference
A biological clock based on DNA methylation, back-spliced exons, expression of LRRK2 mutations, and...
Parkinson's Disease
Article
New therapeutic technologies and targets for Parkinson’s disease
A gastroretentive capsule containing multiple layers of biodegradable film, intraoral infusion via...
Interview
Unmasking the role of autoimmunity
The hypothesis that auto-immunity is a major player in PD is gaining support. Both helper and...
Interview
Targeting the inflammasome
Along with evidence that increased microglial activation could be a key driver of Parkinsons’...
Bipolar
Article
Managing the burdens of bipolar disorder
The cognitive and physiological burdens of bipolar disorder, and some approaches to its treatment,...
Parkinson's Disease
Slide library - The Lundbeck Institute Campus
Neurobiology and aetiology - New Slides for Parkinson’s disease now available
Alzheimer's Disease
Congress highlights
A complete solution for patients with Alzheimer’s disease may be on the horizon
New treatments and improved diagnostic and staging tools will allow for a complete solution for...
Alzheimer's Disease
Congress highlights
Active immunotherapy targets early stage Alzheimer’s disease
Active immunotherapies have been designed to activate an immune response in the human body of...
Alzheimer's Disease
Congress highlights
Initial promise of immunotherapeutics targeting amyloid-β strengthens the possibility of early intervention in Alzheimer’s disease
Clinical studies of immunotherapies show initial promise for early intervention in Alzheimer’...
Alzheimer's Disease
Congress highlights
The many faces of tau offer multiple targets for intervention in Alzheimer’s disease
Tau is a complex, multifaceted target, implicated in many mechanisms involved in the pathology of...
Featured articles
THINC®
Depression
Seminar
THINC® Online Course
Depression - 29.03.2016
Download
Download the THINC-it® Tool
Depression
Download
THINC-it® physician guide
The THINC-it® user guide is now available and can be downloaded here.
Depression
Interview
THINC-it® tool has now been validated! Its importance for measurement-based care in depression
Depression
Article
THINC-it® cognition screening tool now clinically validated
Depression
Article
Infographic for the health care provider describing THINC-it® as a simple, quick and effective way to screen for cognitive dysfunction in depression
Depression
Article
THINC-it® participant leaflet now available
Recommended videos
Video
Two sides of the same coin
7m:19s
Interview
Professor James MacCabe defines Treatment Resistance Schizophrenia
3m:27s
Video
Professor Mark Opler - Teaming up with patients
9m:09s
Video
Improvement in schizophrenia: Long and short term perspectives
Interview
John FP Bridges – Priorities of people living with SCZ
3m:39s
Video
Better understanding of depression, its symptoms and treatment, is needed
3m:39s
Interview
Control of side effects may be the key to solving the dopamine paradox of schizophrenia
3m:44s
Video
Expert insight: on residual and cognitive symptoms in MDD
Interview
John FP Bridges - Aiming for recovery: the world before Schizophrenia
4m:21s
Most popular on Progress in Mind
Depression, Schizophrenia
Article
ICD-11 – fielding for diagnostic success
In 2018, the World Health Organization (WHO) will release two important documents, both of which should aid for the better diagnosis of mental illness; the newer
Depression
Congress highlights
When to change first-line treatment: Debating an everyday dilemma
Schizophrenia
Congress highlights
Mapping of early intervention programs for psychosis in France
Schizophrenia
Congress highlights
Dopamine D2 partial agonists – efficacy, tolerability and improved functioning?
Parkinson's Disease
Congress highlights
Getting rid of alpha-synuclein – active and passive immunotherapy, or maybe targeting LRRK2?
Alzheimer's Disease
Article
Advances in the early diagnosis of Alzheimer’s Disease
Article